Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concurrent interferon-alpha and radiation for head and neck melanoma.

N P Nguyen1, B Levinson, S Dutta

  • 1Department of Radiation Oncology and Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA. NamPhong.Nguyen@med.va.gov

Melanoma Research
|February 6, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning constrained compressed sensing reconstruction improves high-resolution three-dimensional (3D) T2-weighted turbo spin echo magnetic resonance imaging (MRI) of the lumbar spine.

Clinical radiology·2024
Same author

Maternal antioxidant treatment prevents the adverse effects of prenatal stress on the offspring's brain and behavior.

Neurobiology of stress·2020
Same author

Contouring workload in adjuvant breast cancer radiotherapy.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Same author

Serum from differently exercised subjects induces myogenic differentiation in LHCN-M2 human myoblasts.

Journal of sports sciences·2017
Same author

Senecavirus A.

Veterinary pathology·2016
Same author

Challenges for defining minimal clinically important difference (MCID) after spinal cord injury.

Spinal cord·2014

Concurrent systemic interferon-alpha (IFNalpha) with standard radiation fractions showed promise for head and neck melanoma, achieving local control in all patients. Further investigation is warranted despite significant acute toxicity.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Immunotherapy

Background:

  • Melanoma exhibits radioresistance due to sublethal damage repair, often necessitating large radiation doses.
  • High-dose radiation near critical structures increases complication risks, while standard fractionation may compromise efficacy.
  • Concurrent systemic biotherapy with standard radiation fractions offers a potential compromise.

Observation:

  • This study evaluated concurrent systemic interferon-alpha (IFNalpha) and standard radiation fractions in three head and neck melanoma patients.
  • IFNalpha's radiosensitizing properties allowed for standard fractionation, mitigating risks to nearby critical structures.
  • Acute toxicities were significant, leading to treatment interruptions, but resolved post-treatment.

Findings:

Related Experiment Videos

  • All three patients achieved durable local control, with follow-up periods of 24, 18, and 19 months.
  • One patient developed distant metastases, indicating the need for systemic treatment strategies.
  • The combination of IFNalpha and radiation demonstrated feasibility for head and neck melanoma treatment.

    • Implications:

    • Concurrent IFNalpha and radiation is a feasible treatment strategy for head and neck melanoma, warranting larger cohort studies.
    • Significant acute toxicity suggests the potential benefit of incorporating radioprotectors.
    • This approach may offer an alternative to high-dose radiation, balancing efficacy and toxicity.